These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
422 related articles for article (PubMed ID: 27809797)
1. The usefulness of CYFRA 21-1 to diagnose and predict preeclampsia: a nested case-control study. Kuessel L; Zeisler H; Ristl R; Binder J; Pateisky P; Schmid M; Marschalek J; Perkmann T; Haslacher H; Husslein H BMC Pregnancy Childbirth; 2016 Nov; 16(1):339. PubMed ID: 27809797 [TBL] [Abstract][Full Text] [Related]
2. Urine and serum concentrations of Cytokeratin 19 in preeclampsia. Kuessel L; Wild J; Haslacher H; Perkmann T; Ristl R; Zeisler H; Schmid M Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():311-5. PubMed ID: 25203310 [TBL] [Abstract][Full Text] [Related]
3. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia]. Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913 [TBL] [Abstract][Full Text] [Related]
4. Dynamics of serum C-type natriuretic peptide as predictor for preeclampsia. Kuessel L; Zeisler H; Himmler G; Kundi M; Montanari E; Binder J; Husslein H; Marschalek J; Ott J Pregnancy Hypertens; 2018 Oct; 14():286-292. PubMed ID: 29472019 [TBL] [Abstract][Full Text] [Related]
5. Can complete blood count parameters that change according to trimester in pregnancy be used to predict severe preeclampsia? Bulbul M; Uckardes F; Karacor T; Nacar MC; Kaplan S; Kirici P; Surucu A J Obstet Gynaecol; 2021 Nov; 41(8):1192-1198. PubMed ID: 33645411 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal reference ranges for maternal plasma laeverin, and its role as a potential biomarker of preeclampsia. Nystad M; Sitras V; Flo K; Widnes C; Vårtun Å; Wilsgaard T; Acharya G BMC Pregnancy Childbirth; 2016 Nov; 16(1):377. PubMed ID: 27887588 [TBL] [Abstract][Full Text] [Related]
7. Altered Maternal Plasma Glycogen Phosphorylase Isoenzyme BB as a Biomarker for Preeclampsia and Small for Gestational Age. McCarthy FP; Doyle A; Khashan AS; Kenny LC Reprod Sci; 2016 Jun; 23(6):738-47. PubMed ID: 26614266 [TBL] [Abstract][Full Text] [Related]
8. Dynamics of soluble syndecan-1 in maternal serum during and after pregnancies complicated by preeclampsia: a nested case control study. Kuessel L; Husslein H; Montanari E; Kundi M; Himmler G; Binder J; Schiefer J; Zeisler H Clin Chem Lab Med; 2019 Dec; 58(1):50-58. PubMed ID: 31622242 [TBL] [Abstract][Full Text] [Related]
10. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
11. CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis. Cho HY; Kyung MS Med Sci Monit; 2019 Feb; 25():1087-1092. PubMed ID: 30737365 [TBL] [Abstract][Full Text] [Related]
12. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy? Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum leptin as a marker of preeclampsia. El Shahat AM; Ahmed AB; Ahmed MR; Mohamed HS Arch Gynecol Obstet; 2013 Dec; 288(6):1317-22. PubMed ID: 23771185 [TBL] [Abstract][Full Text] [Related]
14. Predictive Value of Maternal Serum Biomarkers for Preeclampsia and Birth Weight: A Case-Control Study in Chinese Pregnant Women. Sun LJ; Xu GF; Lv M; Zhou H; Huang HF; Luo Q J Womens Health (Larchmt); 2018 Dec; 27(12):1519-1524. PubMed ID: 29920141 [TBL] [Abstract][Full Text] [Related]
15. Comparison of serum human pregnancy-specific beta-1-glycoprotein 1 levels in pregnant women with or without preeclampsia. Temur M; Serpim G; Tuzluoğlu S; Taşgöz FN; Şahin E; Üstünyurt E J Obstet Gynaecol; 2020 Nov; 40(8):1074-1078. PubMed ID: 31790616 [TBL] [Abstract][Full Text] [Related]
16. Maternal serum endothelial cell-specific molecule-1 level and its correlation with severity of early-onset preeclampsia. Ovayolu A; Karaman E; Turgut A; Guler S; Bostancieri N J Obstet Gynaecol; 2021 Aug; 41(6):893-898. PubMed ID: 33228435 [TBL] [Abstract][Full Text] [Related]
17. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia? Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016 [TBL] [Abstract][Full Text] [Related]
19. Maternal erythrocyte malondialdehyde level in preeclampsia prediction: a longitudinal study. Basbug M; Demir I; Serin IS; Ozcelik B; Saraymen R; Narin F; Tayyar M J Perinat Med; 2003; 31(6):469-74. PubMed ID: 14711102 [TBL] [Abstract][Full Text] [Related]